Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Preparation and evaluation of nanoparticles for directed tissue engineering.

Hansson A, Di Francesco T, Falson F, Rousselle P, Jordan O, Borchard G.

Int J Pharm. 2012 Dec 15;439(1-2):73-80. doi: 10.1016/j.ijpharm.2012.09.053. Epub 2012 Oct 6.

PMID:
23046666
2.

In vitro evaluation of an RGD-functionalized chitosan derivative for enhanced cell adhesion.

Hansson A, Hashom N, Falson F, Rousselle P, Jordan O, Borchard G.

Carbohydr Polym. 2012 Nov 6;90(4):1494-500. doi: 10.1016/j.carbpol.2012.07.020. Epub 2012 Jul 14.

PMID:
22944407
3.

Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile.

Nafee N, Schneider M, Schaefer UF, Lehr CM.

Int J Pharm. 2009 Nov 3;381(2):130-9. doi: 10.1016/j.ijpharm.2009.04.049. Epub 2009 May 18.

PMID:
19450671
4.

Cellular compatibility of RGD-modified chitosan nanofibers with aligned or random orientation.

Wang YY, Lü LX, Feng ZQ, Xiao ZD, Huang NP.

Biomed Mater. 2010 Oct;5(5):054112. doi: 10.1088/1748-6041/5/5/054112. Epub 2010 Sep 28.

PMID:
20876956
5.

Polysaccharide films built by simultaneous or alternate spray: a rapid way to engineer biomaterial surfaces.

Cado G, Kerdjoudj H, Chassepot A, Lefort M, Benmlih K, Hemmerlé J, Voegel JC, Jierry L, Schaaf P, Frère Y, Boulmedais F.

Langmuir. 2012 Jun 5;28(22):8470-8. doi: 10.1021/la300563s. Epub 2012 May 23.

PMID:
22554108
6.

Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy.

Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, Iadarola P, Genta I.

Eur J Pharm Biopharm. 2008 Sep;70(1):58-65. doi: 10.1016/j.ejpb.2008.04.014. Epub 2008 Apr 27.

PMID:
18547793
7.

Chitosan-hyaluronan/nano chondroitin sulfate ternary composite sponges for medical use.

Anisha BS, Sankar D, Mohandas A, Chennazhi KP, Nair SV, Jayakumar R.

Carbohydr Polym. 2013 Feb 15;92(2):1470-6. doi: 10.1016/j.carbpol.2012.10.058. Epub 2012 Nov 9.

PMID:
23399178
8.

The inhibitory effect of an RGD-human chitin-binding domain fusion protein on the adhesion of fibroblasts to reacetylated chitosan films.

Carvalho V, Domingues L, Gama M.

Mol Biotechnol. 2008 Nov;40(3):269-79. doi: 10.1007/s12033-008-9089-9. Epub 2008 Aug 2.

PMID:
18677572
9.

Synthesis and characterization of chitosan/chondroitin sulfate/nano-SiO2 composite scaffold for bone tissue engineering.

Kavya KC, Dixit R, Jayakumar R, Nair SV, Chennazhi KP.

J Biomed Nanotechnol. 2012 Feb;8(1):149-60.

PMID:
22515103
10.

[Preparation and cytocompatibility of chitosan-based carriers of corneal cells].

Gao X, Liu W, Han B, Wei X.

Sheng Wu Gong Cheng Xue Bao. 2008 Aug;24(8):1381-6. Chinese.

PMID:
18998539
11.

Interactions between chitosan and cells measured by AFM.

Hsiao SW, Thien DV, Ho MH, Hsieh HJ, Li CH, Hung CH, Li HH.

Biomed Mater. 2010 Oct;5(5):054117. doi: 10.1088/1748-6041/5/5/054117. Epub 2010 Sep 28.

PMID:
20876961
12.

Composite chondroitin-6-sulfate/dermatan sulfate/chitosan scaffolds for cartilage tissue engineering.

Chen YL, Lee HP, Chan HY, Sung LY, Chen HC, Hu YC.

Biomaterials. 2007 May;28(14):2294-305. Epub 2007 Feb 2.

PMID:
17298844
13.

Development of bFGF-chitosan matrices and their interactions with human dermal fibroblast cells.

Lefler A, Ghanem A.

J Biomater Sci Polym Ed. 2009;20(10):1335-51. doi: 10.1163/092050609X12457417534295.

PMID:
19622275
14.

In vitro characterization of chitosan-gelatin scaffolds for tissue engineering.

Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV.

Biomaterials. 2005 Dec;26(36):7616-27.

PMID:
16005510
15.

Chitosan-RGDSGGC conjugate as a scaffold material for musculoskeletal tissue engineering.

Masuko T, Iwasaki N, Yamane S, Funakoshi T, Majima T, Minami A, Ohsuga N, Ohta T, Nishimura S.

Biomaterials. 2005 Sep;26(26):5339-47.

PMID:
15814132
16.

Enhancement of osteogenic differentiation of human adipose derived stem cells by the controlled release of platelet lysates from hybrid scaffolds produced by supercritical fluid foaming.

Santo VE, Duarte AR, Popa EG, Gomes ME, Mano JF, Reis RL.

J Control Release. 2012 Aug 20;162(1):19-27. doi: 10.1016/j.jconrel.2012.06.001. Epub 2012 Jun 12.

PMID:
22698936
17.

Chondroitin sulfate in palatal wound healing.

Zou XH, Foong WC, Cao T, Bay BH, Ouyang HW, Yip GW.

J Dent Res. 2004 Nov;83(11):880-5.

PMID:
15505240
18.

Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity.

da Silva LC, Garcia T, Mori M, Sandri G, Bonferoni MC, Finotelli PV, Cinelli LP, Caramella C, Cabral LM.

Int J Nanomedicine. 2012;7:2975-86. doi: 10.2147/IJN.S31632. Epub 2012 Jun 18.

19.

Wound dressings based on silver sulfadiazine solid lipid nanoparticles for tissue repairing.

Sandri G, Bonferoni MC, D'Autilia F, Rossi S, Ferrari F, Grisoli P, Sorrenti M, Catenacci L, Del Fante C, Perotti C, Caramella C.

Eur J Pharm Biopharm. 2013 May;84(1):84-90. doi: 10.1016/j.ejpb.2012.11.022. Epub 2012 Dec 1.

PMID:
23207329
20.

Fabrication of chondroitin sulfate-chitosan composite artificial extracellular matrix for stabilization of fibroblast growth factor.

Mi FL, Shyu SS, Peng CK, Wu YB, Sung HW, Wang PS, Huang CC.

J Biomed Mater Res A. 2006 Jan;76(1):1-15.

PMID:
16224775
Items per page

Supplemental Content

Write to the Help Desk